Click here for international medical scientific information about Oncology for Healthcare Professionals.
Click here for general international information for patients, caregivers and the general public.
This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information
LUME-Meso Phase II/III study: nintedanib + pemetrexed/cisplatin in chemotherapy-naïve patients with malignant pleural mesothelioma
Tsao A, Vogelzang N, Nowak A, Popat S, Gaafar R, van Meerbeeck J, Nakano T, Barrueco J, Morsli N, Scagliotti G
RELATED ARTICLES
Learn more about the science behind this poster in the papers and other materials below
Nintedanib is being investigated in malignant pleural mesothelioma (MPM) and is not approved for this use. The efficacy and safety of nintedanib in MPM have not been established.